ClinicalTrials.gg
Sign In
Drug

Sirolimus Topical Gel PTX-022 clinical trials

Also written PTX-022.

studies test it
6
open now
2
in phase 3
3
first study started
2019

How each study uses Sirolimus Topical Gel PTX-022 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Keep track of what changes. Save the Sirolimus Topical Gel PTX-022 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorisations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Development codes

PTX-022
6

Studies by the year they started

6 studies that test it; most in 2022 (2)

Studies that test Sirolimus Topical Gel PTX-022, by start year
YearStudies
20191
20201
20211
20222
20261

By phase

A phase 1/2 study counts in both.

Phase 2
4
Phase 3
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Basal Cell Nevus Syndrome
1

Who runs them

Industry 6 · Other 0

Palvella Therapeutics, Inc. (6)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test Sirolimus Topical Gel PTX-022.

Studies

Open first, then newest update. How each study uses Sirolimus Topical Gel PTX-022 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 6